The Playbook: Digital Clinical Measures

The Playbook is the essential guide for developing & deploying digital clinical measures across clinical research, clinical care, and population health surveillance. The first draft was developed by a collaboration between DiMe, Elektra Labs, FDA, Genentech, Koneksa Health, Myokardia, Sage Bionetworks, and Scripps Research.

September 2020 on

Underuse of Oral Anticoagulants in Privately Insured Patients with Atrial Fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to ImProve treatment with Oral AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AFib)

Several members of DiMe's leadership participated in a study, published in the American Heart Journal, concludes that there is an unmet need for evidence-based interventions that could lead to greater use of OACs in patients with AF at risk for stroke.

July 2020 in American Heart Journal